We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$60.2M
(-15%)
Cap. Flow
-$87.3M
Cap. Flow
% of AUM
-25.71%
Top 10 Holdings %
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AZEK
The AZEK Co
AZEK
|
+$58.6M |
| 2 |
RDFN
Redfin
RDFN
|
+$35.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.53M |
| 4 |
Sprouts Farmers Market
SFM
|
+$7.45M |
| 5 |
Insmed
INSM
|
+$5.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$30.3M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.3M |
| 3 |
ExxonMobil
XOM
|
+$11.3M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$10.8M |
| 5 |
Pfizer
PFE
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.47% |
| 2 | Real Estate | 13.23% |
| 3 | Healthcare | 10.04% |
| 4 | Financials | 9.26% |
| 5 | Consumer Discretionary | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vail Resorts
MTN
$5.27B
| $1.02M | 0.3% |
+6,519
| New | +$968K |
|
77
Wayfair
W
$11.8B
| $1.02M | 0.3% |
+20,012
| New | +$747K |
|
78
Lucid Motors
LCID
$2.87B
| $1.02M | 0.3% |
+48,349
| New | +$1.16M |
|
79
Las Vegas Sands
LVS
$30.1B
| $1.01M | 0.3% |
+23,232
| New | +$904K |
|
80
Tesla
TSLA
$1.43T
| $1.01M | 0.3% |
+3,167
| New | +$954K |
|
81
AES
AES
$10.5B
| $1.01M | 0.3% |
+95,615
| New | +$1.02M |
|
82
Albemarle
ALB
$14.2B
| $989K | 0.29% |
+15,781
| New | +$933K |
|
83
Franklin Resources
BEN
$17B
| $968K | 0.29% |
+40,590
| New | +$836K |
|
84
Wynn Resorts
WYNN
$10B
| $949K | 0.28% |
+10,127
| New | +$859K |
|
|
BRDG
85
DELISTED
Bridge Investment Group
BRDG
| $928K | 0.27% |
+92,670
| New | +$864K |
|
86
Global E Online
GLBE
$6.4B
| $869K | 0.26% |
+25,895
| New | +$874K |
|
87
VanEck Oil Services ETF
OIH
$2.05B
| $866K | 0.26% |
+3,761
| New | +$844K |
|
88
Waste Management
WM
$96.1B
| $864K | 0.25% |
+3,778
| New | +$876K |
|
89
Jabil
JBL
$31.5B
| $857K | 0.25% |
3,929
-1,571
| -29% | -$255K |
|
90
FB Financial Corp
FBK
$3B
| $844K | 0.25% |
+18,624
| New | +$810K |
|
91
Verisk Analytics
VRSK
$26.3B
| $832K | 0.25% |
+2,670
| New | +$809K |
|
92
Iron Mountain
IRM
$36.8B
| $818K | 0.24% |
+7,978
| New | +$752K |
|
|
EXE
93
Expand Energy Corp
EXE
$21.1B
| $793K | 0.23% |
+6,784
| New | +$757K |
|
94
Fortune Brands Innovations
FBIN
$6.14B
| $785K | 0.23% |
+15,240
| New | +$798K |
|
95
Avis
CAR
$5.67B
| $782K | 0.23% |
+4,627
| New | +$499K |
|
96
Summit Therapeutics
SMMT
$10.7B
| $770K | 0.23% |
+36,187
| New | +$825K |
|
97
EQT Corp
EQT
$31B
| $766K | 0.23% |
+13,131
| New | +$709K |
|
98
Interactive Brokers
IBKR
$40.3B
| $757K | 0.22% |
+13,666
| New | +$648K |
|
99
Independent Bank
INDB
$4.08B
| $756K | 0.22% |
+12,019
| New | +$731K |
|
100
Kiniksa Pharmaceuticals
KNSA
$4.92B
| $749K | 0.22% |
+27,066
| New | +$689K |
|
Similar funds
FS
HIIL
BC
PMAM
LFA
HAM
DP
SPC
Quantessence Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.
- Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
- Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
- Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
- Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
- Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
- Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
- Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.
Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.